5AM Venture Management’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-4,937,646
Closed -$60.7M 26
2022
Q4
$60.7M Hold
4,937,646
16.31% 1
2022
Q3
$162M Buy
4,937,646
+600,000
+14% +$17M 31.05% 1
2022
Q2
$81.7M Hold
4,337,646
20.22% 1
2022
Q1
$76.1M Buy
+4,337,646
New +$89M 16.62% 2

5AM Venture Management's CINC Position: Q1 2023 in Review

5AM Venture Management sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 4,937,646 shares — an estimated $60.7M sold.

5AM Venture Management first reported a position in CINC in Q1 2022 and held it in 4 quarters. The position peaked at $162M in Q3 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

  • 5AM Venture Management reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • 5AM Venture Management sold 4,937,646 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $60.7M.
  • 5AM Venture Management first reported a position in CinCor Pharma, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
  • 5AM Venture Management's CinCor Pharma, Inc. Common Stock position peaked at $162M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on 5AM Venture Management's 13F filing for Q1 2023, filed 15 May 2023.